J Raul Herance is a Miguel Servet researcher who is a Principal Investigator in the Medical Molecular Imaging Group at Vall d’Hebron Research Institute beginning 2015. There, he mainly explores the utility of positron emission tomography (PET) technology for the study of metabolic disorders, personalized medicine and the development of nanomedicine.
He obtained his BA degree in Chemistry at the Autonomous University of Barcelona in 2000 where he also obtained his PhD with honours in the field of organic chemistry and nanotechnology in 2005. He then joined High Technological Institute Foundation at Barcelona Biomedical Research Park, where he received his expertise in molecular imaging.
In 2006 Dr. Herance took the lead of the Chemistry and Radiochemistry Research Unit in the above Foundation.
For the next seven years he has been working in several molecular imaging projects related to PET both in clinical and preclinical trials for drug discovery and development. During this period, he was also an exchange researcher in several International centers including Turku PET Center and the Clinical Imaging Center-Imperial College London.
In 2014, Dr. Herance has been awarded a Miguel Servet grant and expanded his research line in nanomedicine in connection to clinics (diabetes) by working in Dr. Peset Hospital (Valencia) after which he moved to Vall D´Hebron Research Institute (2015) to organize the Medical Molecular Imaging Group.